Source:http://linkedlifedata.com/resource/pubmed/id/16041695
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-9-12
|
pubmed:abstractText |
In a previous study we demonstrated high expression of the non-coding BIC gene in the vast majority of Hodgkin's lymphomas (HLs). Evidence suggesting that BIC is a primary microRNA transcript containing the mature microRNA-155 (miR-155) as part of a RNA hairpin is now accumulating. We therefore analysed HL cell lines and tissue samples to determine whether miR-155 is also expressed in HL. High levels of miR-155 could be demonstrated, indicating that BIC is processed into a microRNA in HL. Most non-HL subtypes were negative for BIC as determined by RNA-ISH. However, in diffuse large B cell lymphoma (DLBCL) and primary mediastinal B cell lymphoma (PMBL), significant percentages of positive tumour cells were observed in 12/18 and 8/8 cases. A higher proportion of tumour cells were positive for BIC in DLBCL with activated B cell-like phenotype than in DLBCL with germinal centre B cell-like phenotype. Differential BIC expression was confirmed by qRT-PCR analysis. Northern blot analysis showed expression of miR-155 in all DLBCL and PMBL derived cell lines and tissue samples analysed. In summary, we demonstrate expression of primary microRNA BIC and its derivative miR-155 in HL, PMBL and DLBCL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-3417
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
207
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
243-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16041695-Cell Line, Tumor,
pubmed-meshheading:16041695-Hodgkin Disease,
pubmed-meshheading:16041695-Humans,
pubmed-meshheading:16041695-Immunohistochemistry,
pubmed-meshheading:16041695-In Situ Hybridization,
pubmed-meshheading:16041695-Lymphoma,
pubmed-meshheading:16041695-Lymphoma, B-Cell,
pubmed-meshheading:16041695-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:16041695-Mediastinal Neoplasms,
pubmed-meshheading:16041695-MicroRNAs,
pubmed-meshheading:16041695-RNA, Neoplasm,
pubmed-meshheading:16041695-Receptors, Antigen, B-Cell,
pubmed-meshheading:16041695-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2005
|
pubmed:articleTitle |
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|